Table of Content

1 Report Overview
1.1 Cardiac Marker Definition
1.2 Market by Type
1.2.1 Global Cardiac Marker Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Creatine kinase (CK) MB
1.2.3 Troponin (cTnI and cTnT)
1.2.4 BNP & NT-proBNP
1.2.5 Myogloblin
1.2.6 Others (hs-CRP, D-Dimer, etc.)
1.3 Market Segment by Application
1.3.1 Global Cardiac Marker Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Cardiac Marker Sales
2.1 Global Cardiac Marker Revenue Estimates and Forecasts 2018-2034
2.2 Global Cardiac Marker Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Cardiac Marker Revenue by Region
2.3.1 Global Cardiac Marker Revenue by Region (2018-2023)
2.3.2 Global Cardiac Marker Revenue by Region (2024-2034)
2.4 Global Cardiac Marker Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Cardiac Marker Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Cardiac Marker Sales Quantity by Region
2.6.1 Global Cardiac Marker Sales Quantity by Region (2018-2023)
2.6.2 Global Cardiac Marker Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Cardiac Marker Sales Quantity by Manufacturers
3.1.1 Global Cardiac Marker Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Cardiac Marker Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Cardiac Marker Sales in 2024
3.2 Global Cardiac Marker Revenue by Manufacturers
3.2.1 Global Cardiac Marker Revenue by Manufacturers (2018-2023)
3.2.2 Global Cardiac Marker Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Cardiac Marker Revenue in 2024
3.3 Global Cardiac Marker Sales Price by Manufacturers
3.4 Global Key Players of Cardiac Marker, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cardiac Marker, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cardiac Marker, Product Offered and Application
3.8 Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Cardiac Marker Sales Quantity by Type
4.1.1 Global Cardiac Marker Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Cardiac Marker Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
4.2 Global Cardiac Marker Revenue by Type
4.2.1 Global Cardiac Marker Historical Revenue by Type (2018-2023)
4.2.2 Global Cardiac Marker Forecasted Revenue by Type (2024-2034)
4.2.3 Global Cardiac Marker Revenue Market Share by Type (2018-2034)
4.3 Global Cardiac Marker Price by Type
4.3.1 Global Cardiac Marker Price by Type (2018-2023)
4.3.2 Global Cardiac Marker Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Cardiac Marker Sales Quantity by Application
5.1.1 Global Cardiac Marker Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Cardiac Marker Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
5.2 Global Cardiac Marker Revenue by Application
5.2.1 Global Cardiac Marker Historical Revenue by Application (2018-2023)
5.2.2 Global Cardiac Marker Forecasted Revenue by Application (2024-2034)
5.2.3 Global Cardiac Marker Revenue Market Share by Application (2018-2034)
5.3 Global Cardiac Marker Price by Application
5.3.1 Global Cardiac Marker Price by Application (2018-2023)
5.3.2 Global Cardiac Marker Price Forecast by Application (2024-2034)
6 North America
6.1 North America Cardiac Marker Sales by Company
6.1.1 North America Cardiac Marker Revenue by Company (2018-2023)
6.1.2 North America Cardiac Marker Sales Quantity by Company (2018-2023)
6.2 North America Cardiac Marker Market Size by Type
6.2.1 North America Cardiac Marker Sales Quantity by Type (2018-2034)
6.2.2 North America Cardiac Marker Revenue by Type (2018-2034)
6.3 North America Cardiac Marker Market Size by Application
6.3.1 North America Cardiac Marker Sales Quantity by Application (2018-2034)
6.3.2 North America Cardiac Marker Revenue by Application (2018-2034)
6.4 North America Cardiac Marker Market Size by Country
6.4.1 North America Cardiac Marker Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Cardiac Marker Revenue by Country (2018-2034)
6.4.3 North America Cardiac Marker Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cardiac Marker Sales by Company
7.1.1 Europe Cardiac Marker Sales Quantity by Company (2018-2023)
7.1.2 Europe Cardiac Marker Revenue by Company (2018-2023)
7.2 Europe Cardiac Marker Market Size by Type
7.2.1 Europe Cardiac Marker Sales Quantity by Type (2018-2034)
7.2.2 Europe Cardiac Marker Revenue by Type (2018-2034)
7.3 Europe Cardiac Marker Market Size by Application
7.3.1 Europe Cardiac Marker Sales Quantity by Application (2018-2034)
7.3.2 Europe Cardiac Marker Revenue by Application (2018-2034)
7.4 Europe Cardiac Marker Market Size by Country
7.4.1 Europe Cardiac Marker Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Cardiac Marker Revenue by Country (2018-2034)
7.4.3 Europe Cardiac Marker Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Cardiac Marker Sales by Company
8.1.1 China Cardiac Marker Sales Quantity by Company (2018-2023)
8.1.2 China Cardiac Marker Revenue by Company (2018-2023)
8.2 China Cardiac Marker Market Size by Type
8.2.1 China Cardiac Marker Sales Quantity by Type (2018-2034)
8.2.2 China Cardiac Marker Revenue by Type (2018-2034)
8.3 China Cardiac Marker Market Size by Application
8.3.1 China Cardiac Marker Sales Quantity by Application (2018-2034)
8.3.2 China Cardiac Marker Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Cardiac Marker Sales by Company
9.1.1 APAC Cardiac Marker Sales Quantity by Company (2018-2023)
9.1.2 APAC Cardiac Marker Revenue by Company (2018-2023)
9.2 APAC Cardiac Marker Market Size by Type
9.2.1 APAC Cardiac Marker Sales Quantity by Type (2018-2034)
9.2.2 APAC Cardiac Marker Revenue by Type (2018-2034)
9.3 APAC Cardiac Marker Market Size by Application
9.3.1 APAC Cardiac Marker Sales Quantity by Application (2018-2034)
9.3.2 APAC Cardiac Marker Revenue by Application (2018-2034)
9.4 APAC Cardiac Marker Market Size by Region
9.4.1 APAC Cardiac Marker Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Cardiac Marker Revenue by Region (2018-2034)
9.4.3 APAC Cardiac Marker Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cardiac Marker Sales by Company
10.1.1 Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Cardiac Marker Market Size by Type
10.2.1 Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Cardiac Marker Market Size by Application
10.3.1 Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Cardiac Marker Market Size by Country
10.4.1 Middle East, Africa and Latin America Cardiac Marker Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 HyTest
11.1.1 HyTest Company Information
11.1.2 HyTest Overview
11.1.3 HyTest Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 HyTest Cardiac Marker Products and Services
11.1.5 HyTest Cardiac Marker SWOT Analysis
11.1.6 HyTest Recent Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Overview
11.2.3 Abbott Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Abbott Cardiac Marker Products and Services
11.2.5 Abbott Cardiac Marker SWOT Analysis
11.2.6 Abbott Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Information
11.3.2 Roche Diagnostics Overview
11.3.3 Roche Diagnostics Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Roche Diagnostics Cardiac Marker Products and Services
11.3.5 Roche Diagnostics Cardiac Marker SWOT Analysis
11.3.6 Roche Diagnostics Recent Developments
11.4 BG Medicine
11.4.1 BG Medicine Company Information
11.4.2 BG Medicine Overview
11.4.3 BG Medicine Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 BG Medicine Cardiac Marker Products and Services
11.4.5 BG Medicine Cardiac Marker SWOT Analysis
11.4.6 BG Medicine Recent Developments
11.5 Biomerieux
11.5.1 Biomerieux Company Information
11.5.2 Biomerieux Overview
11.5.3 Biomerieux Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Biomerieux Cardiac Marker Products and Services
11.5.5 Biomerieux Cardiac Marker SWOT Analysis
11.5.6 Biomerieux Recent Developments
11.6 Critical Diagnostics
11.6.1 Critical Diagnostics Company Information
11.6.2 Critical Diagnostics Overview
11.6.3 Critical Diagnostics Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Critical Diagnostics Cardiac Marker Products and Services
11.6.5 Critical Diagnostics Cardiac Marker SWOT Analysis
11.6.6 Critical Diagnostics Recent Developments
11.7 DiaDexus
11.7.1 DiaDexus Company Information
11.7.2 DiaDexus Overview
11.7.3 DiaDexus Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 DiaDexus Cardiac Marker Products and Services
11.7.5 DiaDexus Cardiac Marker SWOT Analysis
11.7.6 DiaDexus Recent Developments
11.8 Response Biomedical
11.8.1 Response Biomedical Company Information
11.8.2 Response Biomedical Overview
11.8.3 Response Biomedical Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Response Biomedical Cardiac Marker Products and Services
11.8.5 Response Biomedical Cardiac Marker SWOT Analysis
11.8.6 Response Biomedical Recent Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Information
11.9.2 Siemens Healthcare Overview
11.9.3 Siemens Healthcare Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Siemens Healthcare Cardiac Marker Products and Services
11.9.5 Siemens Healthcare Cardiac Marker SWOT Analysis
11.9.6 Siemens Healthcare Recent Developments
11.10 Singulex
11.10.1 Singulex Company Information
11.10.2 Singulex Overview
11.10.3 Singulex Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Singulex Cardiac Marker Products and Services
11.10.5 Singulex Cardiac Marker SWOT Analysis
11.10.6 Singulex Recent Developments
11.11 Thermo Scientific
11.11.1 Thermo Scientific Company Information
11.11.2 Thermo Scientific Overview
11.11.3 Thermo Scientific Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Thermo Scientific Cardiac Marker Products and Services
11.11.5 Thermo Scientific Recent Developments
11.12 Trinity Biotech
11.12.1 Trinity Biotech Company Information
11.12.2 Trinity Biotech Overview
11.12.3 Trinity Biotech Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Trinity Biotech Cardiac Marker Products and Services
11.12.5 Trinity Biotech Recent Developments
11.13 Sunfory
11.13.1 Sunfory Company Information
11.13.2 Sunfory Overview
11.13.3 Sunfory Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Sunfory Cardiac Marker Products and Services
11.13.5 Sunfory Recent Developments
11.14 Lee BioSolutions
11.14.1 Lee BioSolutions Company Information
11.14.2 Lee BioSolutions Overview
11.14.3 Lee BioSolutions Cardiac Marker Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Lee BioSolutions Cardiac Marker Products and Services
11.14.5 Lee BioSolutions Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Cardiac Marker Value Chain Analysis
12.2 Cardiac Marker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cardiac Marker Production Mode & Process
12.4 Cardiac Marker Sales and Marketing
12.4.1 Cardiac Marker Sales Channels
12.4.2 Cardiac Marker Distributors
12.5 Cardiac Marker Customers
13 Market Dynamics
13.1 Cardiac Marker Industry Trends
13.2 Cardiac Marker Market Drivers
13.3 Cardiac Marker Market Challenges
13.4 Cardiac Marker Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Cardiac Marker Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Creatine kinase (CK) MB
Table 3. Major Manufacturers of Troponin (cTnI and cTnT)
Table 4. Major Manufacturers of BNP & NT-proBNP
Table 5. Major Manufacturers of Myogloblin
Table 6. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.)
Table 7. Global Cardiac Marker Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Cardiac Marker Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Cardiac Marker Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Cardiac Marker Revenue Market Share by Region (2018-2023)
Table 11. Global Cardiac Marker Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Cardiac Marker Revenue Market Share by Region (2024-2034)
Table 13. Global Cardiac Marker Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Doses)
Table 14. Global Cardiac Marker Sales by Region (2018-2023) & (K Doses)
Table 15. Global Cardiac Marker Sales Market Share by Region (2018-2023)
Table 16. Global Cardiac Marker Sales by Region (2024-2034) & (K Doses)
Table 17. Global Cardiac Marker Sales Market Share by Region (2024-2034)
Table 18. Global Cardiac Marker Sales Quantity by Manufacturers (2018-2023) & (K Doses)
Table 19. Global Cardiac Marker Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Cardiac Marker Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Cardiac Marker Revenue Share by Manufacturers (2018-2023)
Table 22. Global Cardiac Marker Price by Manufacturers 2018-2023 (USD/Dose)
Table 23. Global Key Players of Cardiac Marker, Industry Ranking, 2021 VS 2024
Table 24. Global Cardiac Marker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Cardiac Marker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Marker as of 2024)
Table 26. Global Key Manufacturers of Cardiac Marker, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Cardiac Marker, Product Offered and Application
Table 28. Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Cardiac Marker Sales Quantity by Type (2018-2023) & (K Doses)
Table 31. Global Cardiac Marker Sales Quantity by Type (2024-2034) & (K Doses)
Table 32. Global Cardiac Marker Sales Quantity Share by Type (2018-2023)
Table 33. Global Cardiac Marker Sales Quantity Share by Type (2024-2034)
Table 34. Global Cardiac Marker Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Cardiac Marker Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Cardiac Marker Revenue Share by Type (2018-2023)
Table 37. Global Cardiac Marker Revenue Share by Type (2024-2034)
Table 38. Cardiac Marker Price by Type (2018-2023) & (USD/Dose)
Table 39. Global Cardiac Marker Price Forecast by Type (2024-2034) & (USD/Dose)
Table 40. Global Cardiac Marker Sales Quantity by Application (2018-2023) & (K Doses)
Table 41. Global Cardiac Marker Sales Quantity by Application (2024-2034) & (K Doses)
Table 42. Global Cardiac Marker Sales Quantity Share by Application (2018-2023)
Table 43. Global Cardiac Marker Sales Quantity Share by Application (2024-2034)
Table 44. Global Cardiac Marker Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Cardiac Marker Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Cardiac Marker Revenue Share by Application (2018-2023)
Table 47. Global Cardiac Marker Revenue Share by Application (2024-2034)
Table 48. Cardiac Marker Price by Application (2018-2023) & (USD/Dose)
Table 49. Global Cardiac Marker Price Forecast by Application (2024-2034) & (USD/Dose)
Table 50. North America Cardiac Marker Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Cardiac Marker Sales Quantity by Company (2018-2023) & (K Doses)
Table 52. North America Cardiac Marker Sales Quantity by Type (2018-2023) & (K Doses)
Table 53. North America Cardiac Marker Sales Quantity by Type (2024-2034) & (K Doses)
Table 54. North America Cardiac Marker Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Cardiac Marker Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Cardiac Marker Sales Quantity by Application (2018-2023) & (K Doses)
Table 57. North America Cardiac Marker Sales Quantity by Application (2024-2034) & (K Doses)
Table 58. North America Cardiac Marker Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Cardiac Marker Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Cardiac Marker Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Cardiac Marker Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Cardiac Marker Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Cardiac Marker Sales Quantity by Country (2018-2023) & (K Doses)
Table 64. North America Cardiac Marker Sales Quantity by Country (2024-2034) & (K Doses)
Table 65. Europe Cardiac Marker Sales Quantity by Company (2018-2023) & (K Doses)
Table 66. Europe Cardiac Marker Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Cardiac Marker Sales Quantity by Type (2018-2023) & (K Doses)
Table 68. Europe Cardiac Marker Sales Quantity by Type (2024-2034) & (K Doses)
Table 69. Europe Cardiac Marker Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Cardiac Marker Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Cardiac Marker Sales Quantity by Application (2018-2023) & (K Doses)
Table 72. Europe Cardiac Marker Sales Quantity by Application (2024-2034) & (K Doses)
Table 73. Europe Cardiac Marker Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Cardiac Marker Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Cardiac Marker Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Cardiac Marker Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Cardiac Marker Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Cardiac Marker Sales Quantity by Country (2018-2023) & (K Doses)
Table 79. Europe Cardiac Marker Sales Quantity by Country (2024-2034) & (K Doses)
Table 80. China Cardiac Marker Sales Quantity by Company (2018-2023) & (K Doses)
Table 81. China Cardiac Marker Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Cardiac Marker Sales Quantity by Type (2018-2023) & (K Doses)
Table 83. China Cardiac Marker Sales Quantity by Type (2024-2034) & (K Doses)
Table 84. China Cardiac Marker Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Cardiac Marker Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Cardiac Marker Sales Quantity by Application (2018-2023) & (K Doses)
Table 87. China Cardiac Marker Sales Quantity by Application (2024-2034) & (K Doses)
Table 88. China Cardiac Marker Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Cardiac Marker Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Cardiac Marker Sales Quantity by Company (2018-2023) & (K Doses)
Table 91. APAC Cardiac Marker Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Cardiac Marker Sales Quantity by Type (2018-2023) & (K Doses)
Table 93. APAC Cardiac Marker Sales Quantity by Type (2024-2034) & (K Doses)
Table 94. APAC Cardiac Marker Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Cardiac Marker Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Cardiac Marker Sales Quantity by Application (2018-2023) & (K Doses)
Table 97. APAC Cardiac Marker Sales Quantity by Application (2024-2034) & (K Doses)
Table 98. APAC Cardiac Marker Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Cardiac Marker Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Cardiac Marker Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Cardiac Marker Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Cardiac Marker Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Cardiac Marker Sales Quantity by Region (2018-2023) & (K Doses)
Table 104. APAC Cardiac Marker Sales Quantity by Region (2024-2034) & (K Doses)
Table 105. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Company (2018-2023) & (K Doses)
Table 106. Middle East, Africa and Latin America Cardiac Marker Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Type (2018-2023) & (K Doses)
Table 108. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Type (2024-2034) & (K Doses)
Table 109. Middle East, Africa and Latin America Cardiac Marker Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Cardiac Marker Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Application (2018-2023) & (K Doses)
Table 112. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Application (2024-2034) & (K Doses)
Table 113. Middle East, Africa and Latin America Cardiac Marker Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Cardiac Marker Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Cardiac Marker Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Cardiac Marker Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Cardiac Marker Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Country (2018-2023) & (K Doses)
Table 119. Middle East, Africa and Latin America Cardiac Marker Sales Quantity by Country (2024-2034) & (K Doses)
Table 120. HyTest Company Information
Table 121. HyTest Description and Overview
Table 122. HyTest Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 123. HyTest Cardiac Marker Product and Services
Table 124. HyTest Cardiac Marker SWOT Analysis
Table 125. HyTest Recent Developments
Table 126. Abbott Company Information
Table 127. Abbott Description and Overview
Table 128. Abbott Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 129. Abbott Cardiac Marker Product and Services
Table 130. Abbott Cardiac Marker SWOT Analysis
Table 131. Abbott Recent Developments
Table 132. Roche Diagnostics Company Information
Table 133. Roche Diagnostics Description and Overview
Table 134. Roche Diagnostics Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 135. Roche Diagnostics Cardiac Marker Product and Services
Table 136. Roche Diagnostics Cardiac Marker SWOT Analysis
Table 137. Roche Diagnostics Recent Developments
Table 138. BG Medicine Company Information
Table 139. BG Medicine Description and Overview
Table 140. BG Medicine Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 141. BG Medicine Cardiac Marker Product and Services
Table 142. BG Medicine Cardiac Marker SWOT Analysis
Table 143. BG Medicine Recent Developments
Table 144. Biomerieux Company Information
Table 145. Biomerieux Description and Overview
Table 146. Biomerieux Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 147. Biomerieux Cardiac Marker Product and Services
Table 148. Biomerieux Cardiac Marker SWOT Analysis
Table 149. Biomerieux Recent Developments
Table 150. Critical Diagnostics Company Information
Table 151. Critical Diagnostics Description and Overview
Table 152. Critical Diagnostics Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 153. Critical Diagnostics Cardiac Marker Product and Services
Table 154. Critical Diagnostics Cardiac Marker SWOT Analysis
Table 155. Critical Diagnostics Recent Developments
Table 156. DiaDexus Company Information
Table 157. DiaDexus Description and Overview
Table 158. DiaDexus Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 159. DiaDexus Cardiac Marker Product and Services
Table 160. DiaDexus Cardiac Marker SWOT Analysis
Table 161. DiaDexus Recent Developments
Table 162. Response Biomedical Company Information
Table 163. Response Biomedical Description and Overview
Table 164. Response Biomedical Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 165. Response Biomedical Cardiac Marker Product and Services
Table 166. Response Biomedical Cardiac Marker SWOT Analysis
Table 167. Response Biomedical Recent Developments
Table 168. Siemens Healthcare Company Information
Table 169. Siemens Healthcare Description and Overview
Table 170. Siemens Healthcare Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 171. Siemens Healthcare Cardiac Marker Product and Services
Table 172. Siemens Healthcare Cardiac Marker SWOT Analysis
Table 173. Siemens Healthcare Recent Developments
Table 174. Singulex Company Information
Table 175. Singulex Description and Overview
Table 176. Singulex Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 177. Singulex Cardiac Marker Product and Services
Table 178. Singulex Cardiac Marker SWOT Analysis
Table 179. Singulex Recent Developments
Table 180. Thermo Scientific Company Information
Table 181. Thermo Scientific Description and Overview
Table 182. Thermo Scientific Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 183. Thermo Scientific Cardiac Marker Product and Services
Table 184. Thermo Scientific Recent Developments
Table 185. Trinity Biotech Company Information
Table 186. Trinity Biotech Description and Overview
Table 187. Trinity Biotech Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 188. Trinity Biotech Cardiac Marker Product and Services
Table 189. Trinity Biotech Recent Developments
Table 190. Sunfory Company Information
Table 191. Sunfory Description and Overview
Table 192. Sunfory Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 193. Sunfory Cardiac Marker Product and Services
Table 194. Sunfory Recent Developments
Table 195. Lee BioSolutions Company Information
Table 196. Lee BioSolutions Description and Overview
Table 197. Lee BioSolutions Cardiac Marker Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 198. Lee BioSolutions Cardiac Marker Product and Services
Table 199. Lee BioSolutions Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Cardiac Marker Distributors List
Table 203. Cardiac Marker Customers List
Table 204. Cardiac Marker Market Trends
Table 205. Cardiac Marker Market Drivers
Table 206. Cardiac Marker Market Challenges
Table 207. Cardiac Marker Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiac Marker Product Picture
Figure 2. Global Cardiac Marker Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Cardiac Marker Market Share by Type in 2024 & 2034
Figure 4. Creatine kinase (CK) MB Product Picture
Figure 5. Troponin (cTnI and cTnT) Product Picture
Figure 6. BNP & NT-proBNP Product Picture
Figure 7. Myogloblin Product Picture
Figure 8. Others (hs-CRP, D-Dimer, etc.) Product Picture
Figure 9. Global Cardiac Marker Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Cardiac Marker Market Share by Application in 2024 & 2034
Figure 11. Myocardial Infarction
Figure 12. Congestive Heart Failure
Figure 13. Acute Coronary Syndrome
Figure 14. Atherosclerosis
Figure 15. Others
Figure 16. Cardiac Marker Report Years Considered
Figure 17. Global Cardiac Marker Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Cardiac Marker Revenue 2018-2034 (US$ Million)
Figure 19. Global Cardiac Marker Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 20. Global Cardiac Marker Sales Quantity 2018-2034 (K Doses)
Figure 21. Global Cardiac Marker Sales Quantity Market Share by Region (2018-2023)
Figure 22. Global Cardiac Marker Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Cardiac Marker Sales Quantity YoY (2018-2034) & (K Doses)
Figure 24. North America Cardiac Marker Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Cardiac Marker Sales Quantity YoY (2018-2034) & (K Doses)
Figure 26. Europe Cardiac Marker Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Cardiac Marker Sales Quantity YoY (2018-2034) & (K Doses)
Figure 28. China Cardiac Marker Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Cardiac Marker Sales Quantity YoY (2018-2034) & (K Doses)
Figure 30. APAC Cardiac Marker Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Cardiac Marker Sales Quantity YoY (2018-2034) & (K Doses)
Figure 32. Middle East, Africa and Latin America Cardiac Marker Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Cardiac Marker Sales Quantity in 2024
Figure 34. The Top 10 and Top 5 Players Market Share by Cardiac Marker Revenue in 2024
Figure 35. Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 36. Global Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Cardiac Marker Revenue Market Share by Type (2018-2034)
Figure 38. Global Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Cardiac Marker Revenue Market Share by Application (2018-2034)
Figure 40. North America Cardiac Marker Revenue Market Share by Company in 2024
Figure 41. North America Cardiac Marker Sales Quantity Market Share by Company in 2024
Figure 42. North America Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Cardiac Marker Revenue Market Share by Type (2018-2034)
Figure 44. North America Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Cardiac Marker Revenue Market Share by Application (2018-2034)
Figure 46. North America Cardiac Marker Revenue Share by Country (2018-2034)
Figure 47. North America Cardiac Marker Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Cardiac Marker Sales Quantity Market Share by Company in 2024
Figure 51. Europe Cardiac Marker Revenue Market Share by Company in 2024
Figure 52. Europe Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Cardiac Marker Revenue Market Share by Type (2018-2034)
Figure 54. Europe Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Cardiac Marker Revenue Market Share by Application (2018-2034)
Figure 56. Europe Cardiac Marker Revenue Share by Country (2018-2034)
Figure 57. Europe Cardiac Marker Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 59. France Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 63. China Cardiac Marker Sales Quantity Market Share by Company in 2024
Figure 64. China Cardiac Marker Revenue Market Share by Company in 2024
Figure 65. China Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Cardiac Marker Revenue Market Share by Type (2018-2034)
Figure 67. China Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Cardiac Marker Revenue Market Share by Application (2018-2034)
Figure 69. APAC Cardiac Marker Sales Quantity Market Share by Company in 2024
Figure 70. APAC Cardiac Marker Revenue Market Share by Company in 2024
Figure 71. APAC Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Cardiac Marker Revenue Market Share by Type (2018-2034)
Figure 73. APAC Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Cardiac Marker Revenue Market Share by Application (2018-2034)
Figure 75. APAC Cardiac Marker Revenue Share by Region (2018-2034)
Figure 76. APAC Cardiac Marker Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 81. India Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Cardiac Marker Sales Quantity Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Cardiac Marker Revenue Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Cardiac Marker Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Cardiac Marker Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Cardiac Marker Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Cardiac Marker Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Cardiac Marker Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Cardiac Marker Revenue Share by Country (2018-2034)
Figure 90. Brazil Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Cardiac Marker Revenue (2018-2034) & (US$ Million)
Figure 95. Cardiac Marker Value Chain
Figure 96. Cardiac Marker Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed